SOX2 and adenocarcinoma: In vitro cell model studies have shown that SOX2 activates lysine-specific demethylase 1 (LSD1), significantly inhibiting the expression of adenocarcinoma-specific genes through epigenetic regulation, while mildly inducing the expression of certain NE markers.